Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Turk Ilac ve Serum Sanayi AS

TRILC-E.IS ✗ NOT COMPLIANTFree checks used up today ☆ Track — members

Istanbul Stock Exchange · Healthcare · Pharmaceuticals ·

Turkey Micro Cap Analyst: N/A

Last Close

$0.02

▼ -2.53%

Market Cap $15.95M · Vol 1.86M

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$15.95M

Micro Cap

Div Yield

0.00%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

35.71

Momentum

Beta

0.97

vs Market

52W High

$0.09

84.15% below

52W Low

$0.01

12.62% above

Volume

1.86M

Avg 3.06M

P/B

1.60

Price-to-book

ROE

N/A

Return on equity

Free Float

73.24%

Public shares

Shariah Compliance8 STANDARDS

✗ Turk Ilac ve Serum Sanayi AS (TRILC-E.IS) stock is currently not Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TRILC-E.IS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-15.38%

-34.75%

-78.31%

YTD

-69.31%

-74.12%

-77.32%

-46.13%

Financials & Valuation

TTM · Annual

Total Revenue	$105.68M
Net Income	$-14,497,150.00
Revenue Growth (YoY)	-56.09%
Gross Margin	35.23%
Operating Margin	25.73%
Net Profit Margin	-13.72%
ROE	N/A
ROA · ROIC	-8.44% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.57
P/B	1.60
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	1.04B

Technical Indicators

50-Day SMA	$0.02
200-Day SMA	$0.04
RSI (14)	35.71
Beta	0.97
52-Week High	$0.09
52-Week Low	$0.01

Volume Today	1.86M
Avg Daily Volume (30D)	3.06M
Relative Volume	0.61x
Volatility (10D)	51.88
Volatility (30D)	71.30
Free Float	73.24%

Analyst Consensus

N/A

Current Price $0.02

Mean Target N/A

52W Low$0.01 52W High$0.09

Current

Target

$0.01 $0.09

Current Analyst target

· 0 analysts

Identifiers

ExchangeIstanbul Stock Exchange

FIGIBBG00ZF07KQ5

ISINTRETRLC00022

CountryTurkey

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Company -0.70% JNJ Johnson & Johnson +1.11% ABBV AbbVie Inc. -0.18% NVS Novartis AG -0.04% NOVN.S Novartis AG +1.11%

Company Profile

Turk Ilac ve Serum Sanayi AS is a Turkey-based pharmaceutical company. The main activity of the Company is to manufacture and sell all kinds of tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids and other chemical substances. The company also acts as the representative or sales agency of other domestic and foreign pharmaceutical companies, as well as importing and marketing veterinary, cosmetics and pesticides. Turk Ilac manufactures in accordance with Current Good Manufacturing (GMP) and Good Laboratory Practice (GLP) principles with its approximately 300 employees in its facilities on a total area of 56.000 square meters in the Ankara - Akyurt region.